NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NutriBand's profit margin for the twelve months ending Jul 31, 2026 was -430.4%. For fiscal 2026 it was -404.1%, against -489.9% the year before. The highest annual figure on record is -215.6% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -404.1% | +85.9 |
| FY2025 | Jan 31, 2025 | -489.9% | −226.9 |
| FY2024 | Jan 31, 2024 | -263.0% | −47.5 |
| FY2023 | Jan 31, 2023 | -215.6% | +218.7 |
| FY2022 | Jan 31, 2022 | -434.3% | −123.5 |
| FY2021 | Jan 31, 2021 | -310.8% | +1969.3 |
| FY2020 | Jan 31, 2020 | -2280.1% | −922.0 |
| FY2019 | Jan 31, 2019 | -1358.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -201.3% | +120.1 |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -286.6% | −78.5 |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -241.6% | +617.2 |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -1119.0% | −908.0 |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -321.4% | +63.8 |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -208.1% | +256.5 |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -858.8% | −500.2 |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -211.0% | +200.4 |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -385.1% | −258.7 |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -464.6% | −251.7 |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -358.5% | −40.2 |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -411.4% | −237.3 |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -126.4% | +101.3 |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -212.9% | −68.5 |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -318.3% | +447.8 |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -174.0% | −101.1 |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -227.7% | +419.3 |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -144.4% | −133.5 |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -766.1% | −498.7 |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -72.9% | +272.4 |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -647.0% | +4177.2 |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -10.9% | +901.5 |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -267.5% | +334.0 |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -345.3% | −49.2 |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -4824.2% | −4198.8 |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -912.3% | −612.2 |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -601.5% | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -296.2% | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -625.4% | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -300.1% | – |
See a number that looks wrong?